All Stories

  1. A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

    Article • Clinical Epidemiology, March 2018, Dove Medical Press

    Mr Anton Pottegård, Dr Susana Perez-Gutthann

  2. Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany

    Article • Pharmacoepidemiology and Drug Safety, January 2017, Wiley

    Dr Alexandra Prados-Torres, Dr Susana Perez-Gutthann, Dr Marie Elisabeth Linder

  3. Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources

    Article • Seminars in Arthritis and Rheumatism, February 2015, Elsevier

    Dr Susana Perez-Gutthann

  4. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank

    Article • Clinical Epidemiology, October 2014, Taylor & Francis

    Dr Susana Perez-Gutthann, Dr Andrea V Margulis

  5. The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies

    Article • BMC Cardiovascular Disorders, September 2014, Springer Science + Business Media

    Dr Susana Perez-Gutthann, Dr Andrea V Margulis

  6. Response to the letter to the editor entitled “Diclofenac: Increase of myocardial infarctions at low doses?” (PDS 13‐0441) authored by K Brune

    Article • Pharmacoepidemiology and Drug Safety, March 2014, Wiley

    Dr Susana Perez-Gutthann

  7. Validation of Acute Liver Injury Cases in a Population-Based Cohort Study of Oral Antimicrobial Users

    Article • Current Drug Safety, February 2014, Bentham Science Publishers

    Dr Susana Perez-Gutthann

  8. Risk of Acute Liver Injury Associated with the Use of Moxifloxacin and Other Oral Antimicrobials: A Retrospective, Population‐Based Cohort Study

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2013, Wiley

    Dr Susana Perez-Gutthann

  9. Changes in the landscape of health care database research from 2000 to 2011

    Article • August 2013, RTI Press

    Dr Susana Perez-Gutthann

  10. Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti‐inflammatory drugs users in Friuli ...

    Article • Pharmacoepidemiology and Drug Safety, August 2013, Wiley

    Dr Susana Perez-Gutthann

  11. Myocardial infarction and individual nonsteroidal anti‐inflammatory drugs meta‐analysis of observational studies

    Article • Pharmacoepidemiology and Drug Safety, April 2013, Wiley

    Dr Susana Perez-Gutthann

  12. Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen)

    Article • Drug Safety, January 2013, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  13. Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care...

    Article • BMJ Open, January 2013, BMJ

    Dr Susana Perez-Gutthann

  14. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti‐inflammatory drugs in Friuli Venezia Giulia, Italy

    Article • Pharmacoepidemiology and Drug Safety, December 2012, Wiley

    Dr Susana Perez-Gutthann

  15. Individual NSAIDs and Upper Gastrointestinal Complications

    Article • Drug Safety, December 2012, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  16. Individual NSAIDs and Upper Gastrointestinal Complications

    Article • Drug Safety, December 2012, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  17. Methodology for a multinational case–population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT)

    Article • European Journal of Clinical Pharmacology, August 2012, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  18. Stroke risk and NSAIDs: a systematic review of observational studies

    Article • Pharmacoepidemiology and Drug Safety, October 2011, Wiley

    Dr Susana Perez-Gutthann

  19. SALT-I (Study of Acute Liver Transplant) : étude de l’insuffisance hépatique aiguë liée aux AINS dans des centres de transplantation hépatique européens

    Article • Revue d Épidémiologie et de Santé Publique, October 2011, Elsevier

    Dr Susana Perez-Gutthann

  20. P73 Preliminary results of the Study of Acute Liver Transplant (SALT): NSAID exposure and risk of acute liver failure leading to transplantation in 7 European countries

    Article • Gut, September 2011, BMJ

    Dr Susana Perez-Gutthann

  21. Risk of Upper Gastrointestinal Complications Associated with Cyclooxygenase‐2 Selective and Nonselective Nonsteroidal Antiinflammatory Drugs

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2009, Wiley

    Dr Susana Perez-Gutthann

  22. The use of selective cyclooxygenase‐2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

    Article • Pharmacoepidemiology and Drug Safety, August 2009, Wiley

    Dr Susana Perez-Gutthann

  23. Positive predictive value of ICD‐9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database

    Article • Pharmacoepidemiology and Drug Safety, May 2008, Wiley

    Dr Susana Perez-Gutthann

  24. Use of oral corticosteroids and the risk of acute myocardial infarction

    Article • Atherosclerosis, June 2007, Elsevier

    Dr Susana Perez-Gutthann

  25. A call for international harmonization in therapeutic risk management

    Article • Pharmacoepidemiology and Drug Safety, September 2006, Wiley

    Dr Susana Perez-Gutthann

  26. Quantitative assessment of the gastrointestinal and cardiovascular risk‐benefit of celecoxib compared to individual NSAIDs at the population level

    Article • Pharmacoepidemiology and Drug Safety, August 2006, Wiley

    Dr Susana Perez-Gutthann

  27. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: A case/noncase analysis of spontaneous reports

    Article • Clinical Therapeutics, August 2006, Elsevier

    Dr Susana Perez-Gutthann

  28. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan

    Article • European Journal of Clinical Pharmacology, July 2006, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  29. Pharmacovigilance during the Pre-Approval Phases

    Article • Drug Safety, January 2006, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  30. Twentieth annual conference on pharmacoepidemiology and therapeutic risk management

    Article • Pharmacoepidemiology and Drug Safety, July 2005, Wiley

    Dr Susana Perez-Gutthann

  31. The UK General Practice Research Database

    Article • August 2000, Wiley

    Dr Susana Perez-Gutthann

  32. Hormone Replacement Therapy and Incidence of Acute Myocardial Infarction

    Article • Circulation, June 2000, Wolters Kluwer Health

    Dr Susana Perez-Gutthann

  33. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study

    Article • Climacteric, January 2000, Taylor & Francis

    Dr Susana Perez-Gutthann

  34. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs

    Article • British Journal of Clinical Pharmacology, December 1999, Wiley

    Dr Susana Perez-Gutthann

  35. Low‐Dose Diclofenac, Naproxen, and Ibuprofen Cohort Study

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 1999, Wiley

    Dr Susana Perez-Gutthann

  36. THE AUTHORS REPLY

    Article • American Journal of Epidemiology, February 1999, Oxford University Press (OUP)

    Dr Susana Perez-Gutthann

  37. Principles of epidemiological research on adverse and beneficial drug effects

    Article • The Lancet, November 1998, Elsevier

    Dr Susana Perez-Gutthann

  38. Use of the UK General Practice Research Database for pharmacoepidemiology

    Article • British Journal of Clinical Pharmacology, May 1998, Wiley

    Dr Susana Perez-Gutthann

  39. Hormone Replacement Therapy and the Risk of Hospitalization for Venous Thromboembolism: A Population-based Study in Southern Europe

    Article • American Journal of Epidemiology, February 1998, Oxford University Press (OUP)

    Dr Susana Perez-Gutthann

  40. Individual Nonsteroidal Antiinflammatory Drugs and Other Risk Factors for Upper Gastrointestinal Bleeding and Perforation

    Article • Epidemiology, January 1997, Wolters Kluwer Health

    Dr Susana Perez-Gutthann

  41. Nonsteroidal Anti-inflammatory Drugs and the Risk of Hospitalization for Acute Renal Failure

    Article • Archives of Internal Medicine, November 1996, American Medical Association (AMA)

    Dr Susana Perez-Gutthann

  42. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure

    Article • Archives of Internal Medicine, November 1996, American Medical Association (AMA)

    Dr Susana Perez-Gutthann

  43. Positive Predictive Value of ICD-9 Codes in the Identification of Cases of Complicated Peptic Ulcer Disease in the Saskatchewan Hospital Automated Database

    Article • Epidemiology, January 1996, Wolters Kluwer Health

    Dr Susana Perez-Gutthann

  44. The Increased Risk of Hospitalizations for Acute Liver Injury in a Population with Exposure to Multiple Drugs

    Article • Epidemiology, November 1993, Wolters Kluwer Health

    Dr Susana Perez-Gutthann

  45. The Role of Non-steroidal Anti-inflammatory Drugs in Acute Liver Injury

    Article • Survey of Anesthesiology, June 1993, Wolters Kluwer Health

    Dr Susana Perez-Gutthann

  46. Risk factors for coronary artery disease in patients with systemic lupus erythematosus

    Article • The American Journal of Medicine, November 1992, Elsevier

    Dr Susana Perez-Gutthann

  47. The role of non-steroidal anti-inflammatory drugs in acute liver injury.

    Article • BMJ, October 1992, BMJ

    Dr Susana Perez-Gutthann

  48. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

    Article • Pediatric Nephrology, July 1992, Springer Science + Business Media

    Dr Susana Perez-Gutthann

  49. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status

    Article • The American Journal of Medicine, October 1991, Elsevier

    Dr Susana Perez-Gutthann